Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetails
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetailsHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreDetailsNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read moreDetails
By Aakar Patel As a democratic society, it is expected that India’s authorities follow the rule of law. This includes...
Read moreDetails
By Dilip Cherian Three hours is barely enough time for a working lunch in New Delhi. Yet when UAE President...
Read moreDetails
Invariably US President Donald Trump says one thing and means something completely different has, by now, become clear to the...
Read moreDetails
We are aware how, once the month of January gets over, the rest of the year flies past in the...
Read moreDetails
